No one wants to pay more tax. And the richest of us protest most and fight hardest when asked to cough up a little more.

Bioceres is under pressure from weak ag markets, tightening cash flow, and delayed product impact despite a lower valuation.

Armed groups lost access to dollars when a banking loophole was closed. They quickly pivoted to exploit a currency-exchange ...

FY25 saw record IPO and QIP fundraising, but most capital hasn't fueled new projects. Like FY24, funds largely went to debt ...

The US economy shrank at the start of the year, restrained by weaker consumer spending and an even bigger impact from trade ...

Latest global economic developments, including US contraction, Canadian export surge, India's growth, and more, featured on ...

As California's employee classification law, AB5, gains legal ground, ports like Los Angeles and Long Beach could soon see major shifts in how independent ...

Wage growth has slowed since spiking in 2022, and fewer CEOs have plans to raise pay in the next year. Indeed's career trends ...

Only eight stocks in the entire S&P 500 have triggered a bullish “Golden Cross” pattern in the past week. But here’s what ...

The Texas-based, private equity-backed company that bought DVM Manufacturing LLC and its busy West Chester switchgear factory ...

The dizzying, supercollider pace of energy investment in Wyoming — especially nuclear — is bringing waves of new faces into ...

Staffing shortages are a pressing issue for all physician specialists, but they impact certain specialties in different ways. For orthopedic surgeons, backups in ORs caused by other, emergent ...